NO902802L - Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus. - Google Patents

Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.

Info

Publication number
NO902802L
NO902802L NO90902802A NO902802A NO902802L NO 902802 L NO902802 L NO 902802L NO 90902802 A NO90902802 A NO 90902802A NO 902802 A NO902802 A NO 902802A NO 902802 L NO902802 L NO 902802L
Authority
NO
Norway
Prior art keywords
glycoproteins
human respiratory
gymoprotein
chemical
containing immunogenic
Prior art date
Application number
NO90902802A
Other languages
English (en)
Other versions
NO902802D0 (no
NO300254B1 (no
Inventor
Michael Wathen
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of NO902802D0 publication Critical patent/NO902802D0/no
Publication of NO902802L publication Critical patent/NO902802L/no
Publication of NO300254B1 publication Critical patent/NO300254B1/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2319/00Fusion polypeptide
    • C07K2319/01Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011Details
    • C12N2760/18011Paramyxoviridae
    • C12N2760/18511Pneumovirus, e.g. human respiratory syncytial virus
    • C12N2760/18522New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
NO902802A 1987-12-23 1990-06-22 Fremgangsmåte for fremstilling av en vaksine mot humant respiratorisk syncytielt virus NO300254B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13738787A 1987-12-23 1987-12-23
PCT/US1988/003784 WO1989005823A1 (en) 1987-12-23 1988-10-31 Chimeric glycoproteins containing immunogenic segments of the glycoproteins of human respiratory syncytial virus

Publications (3)

Publication Number Publication Date
NO902802D0 NO902802D0 (no) 1990-06-22
NO902802L true NO902802L (no) 1990-06-22
NO300254B1 NO300254B1 (no) 1997-05-05

Family

ID=22477194

Family Applications (1)

Application Number Title Priority Date Filing Date
NO902802A NO300254B1 (no) 1987-12-23 1990-06-22 Fremgangsmåte for fremstilling av en vaksine mot humant respiratorisk syncytielt virus

Country Status (14)

Country Link
US (2) US5194595A (no)
EP (1) EP0396563B1 (no)
JP (1) JP2716503B2 (no)
KR (1) KR0137963B1 (no)
AT (1) ATE85622T1 (no)
AU (1) AU617739B2 (no)
CA (1) CA1320163C (no)
DE (1) DE3878468T2 (no)
DK (1) DK173175B1 (no)
FI (1) FI102382B1 (no)
HK (1) HK166295A (no)
MX (1) MX9203458A (no)
NO (1) NO300254B1 (no)
WO (1) WO1989005823A1 (no)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8914968D0 (en) * 1989-06-29 1989-08-23 Connaught Lab Production of virus and purification of viral envelope proteins for vaccine use
US6004563A (en) * 1990-11-07 1999-12-21 American Home Products Corporation Feline vaccine compositions and method for preventing chlamydia infections or diseases using the same
US5824307A (en) * 1991-12-23 1998-10-20 Medimmune, Inc. Human-murine chimeric antibodies against respiratory syncytial virus
GB9200117D0 (en) * 1992-01-06 1992-02-26 Connaught Lab Production of recombinant chimeric proteins for vaccine use
GB9207479D0 (en) * 1992-04-06 1992-05-20 Scotgen Ltd Novel antibodies for treatment and prevention of respiratory syncytial virus infection in animals and man
TW275632B (no) * 1992-04-21 1996-05-11 American Cyanamid Co
AU5955294A (en) * 1993-01-08 1994-08-15 Upjohn Company, The Process for the purification and refolding of human respiratory syncytial virus fg glycoprotein
AU676340B2 (en) * 1993-05-25 1997-03-06 Wyeth Holdings Corporation Adjuvants for vaccines against respiratory syncytial virus
DE69536065D1 (de) * 1994-01-14 2010-05-27 Rath Matthias Hydrophile Signal-Oligopeptide und Verfahren der therapeutischen Anwendung
US7300918B2 (en) 1994-01-14 2007-11-27 Matthias Rath Method of producing vaccines from protein signal oligopeptides
FR2718452B1 (fr) 1994-04-06 1996-06-28 Pf Medicament Elément d'immunogène, agent immunogène, composition pharmaceutique et procédé de préparation.
US5716821A (en) * 1994-09-30 1998-02-10 Uab Research Foundation Prevention and treatment of respiratory tract disease
WO1996010400A1 (en) * 1994-09-30 1996-04-11 The Uab Research Foundation Gene therapy vectors and vaccines based on non-segmented negatives stranded rna viruses
FR2726472B1 (fr) 1994-11-07 1997-01-31 Pf Medicament Proteine porteuse a effet adjuvant, complexe immunogene la contenant, leur procede de preparation, sequence nucleotidique et vaccin
DE4442114A1 (de) * 1994-11-25 1996-05-30 Buna Sow Leuna Olefinverb Gmbh Nitrit-, phosphat- und aminfreies Kühl- und Wärmeübertragungsmittel
US5811524A (en) * 1995-06-07 1998-09-22 Idec Pharmaceuticals Corporation Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof
US6015664A (en) * 1995-11-03 2000-01-18 Mcw Research Foundation Multiplex PCR assay using unequal primer concentrations to detect HPIV 1,2,3 and RSV A,B and influenza virus A, B
AU6908598A (en) * 1996-10-29 1998-05-22 Smithkline Beecham Biologicals (Sa) Purification of respiratory syncytial virus antigens
EP1002068B1 (en) * 1997-07-14 2009-09-09 University of Liège Mutations in the myostatin gene cause double-muscling in mammals
US20070067859A1 (en) * 1997-07-14 2007-03-22 Michel Georges Double-muscling in mammals
US6103466A (en) * 1997-07-14 2000-08-15 University Of Liege Double-muscling in mammals
US6699478B1 (en) * 1997-09-19 2004-03-02 Wyeth Holdings Corporation Enhanced immune response to attachment (G) protein of Respiratory Syncytial Virus
GB9909077D0 (en) 1999-04-20 1999-06-16 Smithkline Beecham Biolog Novel compositions
JP4992068B2 (ja) * 2000-01-27 2012-08-08 メディミューン,エルエルシー 超高親和性中和抗体
EP2341075A1 (en) * 2000-03-01 2011-07-06 MedImmune, LLC Antibodies binding to the f protein of a respiratory syncytial virus (rsv)
US6855493B2 (en) 2000-11-28 2005-02-15 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7179900B2 (en) * 2000-11-28 2007-02-20 Medimmune, Inc. Methods of administering/dosing anti-RSV antibodies for prophylaxis and treatment
US7132100B2 (en) 2002-06-14 2006-11-07 Medimmune, Inc. Stabilized liquid anti-RSV antibody formulations
DE602005018473D1 (de) * 2004-05-24 2010-02-04 Polymun Scient Immunbio Forsch Superbeladene liposome für die arzneimittelabgabe
WO2006050166A2 (en) * 2004-10-29 2006-05-11 Medimmune, Inc. Methods of preventing and treating rsv infections and related conditions
EP1997830A1 (en) 2007-06-01 2008-12-03 AIMM Therapeutics B.V. RSV specific binding molecules and means for producing them
DK2222710T3 (en) 2007-12-24 2016-10-03 Id Biomedical Corp Quebec Recombinant RSV antigens.
EA201170217A1 (ru) * 2008-07-18 2011-08-30 АйДи БАЙОМЕДИКАЛ КОРПОРЕЙШН ОФ КВЕБЕК Гибридные полипептидные антигены респираторно-синцитиального вируса
PE20121541A1 (es) 2009-06-24 2012-12-21 Glaxosmithkline Biolog Sa Antigenos de virus de sincicio respiratorio recombinantes
EP4218799A1 (en) 2009-07-15 2023-08-02 GlaxoSmithKline Biologicals S.A. Rsv f protein compositions and methods for making same
US8568726B2 (en) 2009-10-06 2013-10-29 Medimmune Limited RSV specific binding molecule
EA201891945A3 (ru) 2012-08-01 2019-05-31 Бавариан Нордик А/С Вакцина рекомбинантного модифицированного вируса осповакцины анкара (mva) респираторно-синцитиального вируса (rsv)

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4855224A (en) * 1984-03-09 1989-08-08 Genentech, Inc. Molecularly cloned diagnostic product and method of use
WO1987004185A1 (en) * 1986-01-14 1987-07-16 University Of North Carolina Vaccines for human respiratory virus
US5223254A (en) * 1987-09-29 1993-06-29 Praxis Biologics, Inc. Respiratory syncytial virus: vaccines
US5001230A (en) * 1988-02-18 1991-03-19 Schering Corporation T cell activation markers
SG106639A1 (en) * 2000-10-10 2004-10-29 Gen Electric Apparatus and method for introducing small amounts of refractory elements into a vapor deposition coating

Also Published As

Publication number Publication date
FI903154A0 (fi) 1990-06-21
US5194595A (en) 1993-03-16
EP0396563A1 (en) 1990-11-14
DK173175B1 (da) 2000-03-06
DK153290A (da) 1990-08-16
EP0396563B1 (en) 1993-02-10
FI102382B (fi) 1998-11-30
WO1989005823A1 (en) 1989-06-29
NO902802D0 (no) 1990-06-22
DE3878468T2 (de) 1993-06-09
US5288630A (en) 1994-02-22
DE3878468D1 (de) 1993-03-25
CA1320163C (en) 1993-07-13
DK153290D0 (da) 1990-06-22
ATE85622T1 (de) 1993-02-15
KR900700508A (ko) 1990-08-13
FI102382B1 (fi) 1998-11-30
AU2785089A (en) 1989-07-19
MX9203458A (es) 1992-09-01
HK166295A (en) 1995-11-03
NO300254B1 (no) 1997-05-05
JPH03501723A (ja) 1991-04-18
JP2716503B2 (ja) 1998-02-18
KR0137963B1 (ko) 1998-04-30
AU617739B2 (en) 1991-12-05

Similar Documents

Publication Publication Date Title
NO902802D0 (no) Kimaere glykoproteiner inneholdende immunogene segmenter av glykoproteinene fra human respiratorisk syncytielt virus.
NO904538L (no) Kimaere glykoproteiner inneholdende immunogene segmenter av humant parainfluensavirus type 3.
DE3856141T2 (de) Respiratorisches syncytiales virus, impstoffe
ES500567A0 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
EP0855918A4 (en) INTERLEUKIN-15 FROM CHICKEN AND USES THEREOF
DE60041280D1 (de) Chimäre mensch-rinder respiratory syncytial virus vakzinen
HK51597A (en) Vaccines for human respiratory virus
KR890700030A (ko) 인플루엔자균(Haemophilus influenzae)의 백신 및 진단방법
ATE234917T1 (de) Avirulente salmonella mikroben mit einer mutation in dem cdt gen und ihre verwendung
ATE346931T1 (de) Clostridium perfringens impfstoff
DK311485D0 (da) Fremgangsmaade til fremstilling af ikke-toksisk lt-b-underenhed i e. coli-enterotoksin
ATE73349T1 (de) Hepatitisoberflaechenantigenpartikelvakzin.
MY101874A (en) Vaccine
DE3582422D1 (de) Biologische zubereitungen.
ATE15501T1 (de) Impfstoff fuer gefluegel gegen ansteckende bronchitis, zusammengesetzte impfstoffe gegen ansteckende bronchitis, verfahren zu deren herstellung und virusstamm der ansteckenden bronchitis.
EP1082011A4 (en) AVIAN POLYOMA VIRUS VACCINES FOR PSITTACIDS

Legal Events

Date Code Title Description
MK1K Patent expired